Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Croatia
Management Report
Published: January 2010
Pages: 28
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
The Republic of Croatia is located in south-eastern Europe and is bordered by Slovenia, Hungary, Serbia, Bosnia-Herzegovina and Montenegro. The population stands at an estimated 4.5 million in 2010, of whom 18.0% are aged 65 or over. Croatia is on track for EU accession by 2011 following the arrest of the war crimes suspect General Ante Gotovina. The government is aiming to bring the performance of the healthcare system into line with that of other EU member states through the National Health Strategy 2006-2011.
Around 69% of the pharmaceutical market is supplied by imports. Germany and Slovenia were the leading suppliers in 2007, accounting for over 30% of imports; countries from the EU-27 were the suppliers of 81% of all imports. The value of imports increased by over 16% in 2007.
Domestic production is dominated by Pliva, which was acquired by the US company, Barr Pharmaceuticals, in October 2006. The combination of Barr and Pliva creates the third largest global generic pharmaceutical company, in terms of revenue. In 2007, Teva acquired Barr Pharmaceuticals and thus Pliva became part of the Teva Group. Pliva reported annual sales of US$1.1 billion in year ending December 2007.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel
Around 69% of the pharmaceutical market is supplied by imports. Germany and Slovenia were the leading suppliers in 2007, accounting for over 30% of imports; countries from the EU-27 were the suppliers of 81% of all imports. The value of imports increased by over 16% in 2007.
Domestic production is dominated by Pliva, which was acquired by the US company, Barr Pharmaceuticals, in October 2006. The combination of Barr and Pliva creates the third largest global generic pharmaceutical company, in terms of revenue. In 2007, Teva acquired Barr Pharmaceuticals and thus Pliva became part of the Teva Group. Pliva reported annual sales of US$1.1 billion in year ending December 2007.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel